SelectScience InterviewsLife Sciences
Detection of Breast Cancer-Related Germline Mutations with Advanced NGS Technology
13 Aug 2019
As breast cancer remains the most common tumor in women worldwide, identifying relevant germline predisposing mutations is important in determining a patient’s lifetime risk of developing breast cancer and allows early detection, clinical management and treatment. Through advances in next-generation sequencing technology, Dr. Valeria D’Argenio, Federico II University and CEINGE Biotecnologie Avanzate, Italy, discusses data from six years of experience in hereditary breast cancer diagnosis using BRCA amplicon sequencing and custom panel analysis.
About the company

SelectScience
Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.





















